DEEF Pharmaceutical

What DEEF Pharmaceutical does

DEEF Pharmaceutical is a private, for-profit pharmaceutical products company headquartered in Riyadh, Saudi Arabia. Founded in 2002, it operates in the Kingdom's regulated pharmaceutical sector, which is overseen by the Saudi Food and Drug Authority (SFDA) and includes product licensing, GMP compliance, and registration requirements as standard market entry conditions.

The company's public footprint is minimal in the available data: its website (deef.com) returns only a verification/loading page with no substantive product, technology, or commercial information, and there are no disclosed details on its product portfolio, manufacturing footprint, distribution model, or specific therapeutic areas served. No proprietary technology, patents, certifications, or partnerships are documented in the input.

On the commercial side, revenue model, pricing, customer segments, and go-to-market channels are not disclosed. The leadership table identifies Ashraf Abu Arrah as Chief Executive Officer. Given the absence of disclosed financials, headcount, funding history, or strategic moves in the input, any deeper characterization of the business model, scale, or growth profile would be unsupported and is intentionally omitted.

Name

DEEF Pharmaceutical

Website

https://deef.com

Company type

Private

Founded year

2020

Headcount range

51–100 employees

Short description

DEEF Pharmaceutical is a Riyadh-based, privately held pharmaceutical products company founded in 2002, operating in the Saudi Arabian market under SFDA regulatory oversight. It is led by CEO Ashraf Abu Arrah, with no public disclosure of product portfolio or financials.

Ownership category

akta.pro rank

Product category

Pharmaceutical Products

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industries

Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD), Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

Keywords

• Pharmaceutical products
• Generic medicines
• Pharmaceutical distribution
• Healthcare supplies
• Drug manufacturing

Headquarters

HQ city

Jeddah

HQ country

Saudi Arabia

HQ region

Middle East

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Core offering

DEEF Pharmaceutical supplies pharmaceutical products to the Saudi market. The company is a privately held for-profit entity headquartered in Riyadh, Saudi Arabia, established in 2002, and operates within the healthcare products supply chain.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Products Pharmaceutical products supplied to the Saudi healthcare market; intended for pharmacies, hospitals, clinics, and other healthcare buyers.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Tabuk Pharmaceuticals: Major Saudi pharmaceutical manufacturer focused on branded generics. Comparable as a domestic pharma product supplier competing for the same Saudi institutional and retail customers.
• SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation): Leading Saudi-based pharmaceutical manufacturer and distributor listed on Tadawul. Directly comparable as a Riyadh-headquartered pharma supplier serving Saudi public and private healthcare channels.
• Saudi Pharmaceutical Industries (SPI): Saudi pharmaceutical manufacturer specializing in generics and injectables. Comparable as a domestic pharma product supplier competing in similar Saudi institutional channels.
• Avalon Pharma: Saudi pharmaceutical company producing and distributing branded generics and consumer health products. Directly comparable as a domestic pharma supplier targeting Saudi and regional customers.

Regional players

• Pharco Pharmaceuticals: Egypt-headquartered pharmaceutical manufacturer exporting across MENA. Comparable as a regional pharma product supplier competing for the same institutional customers in broader Arab markets.
• Julphar (Gulf Pharmaceutical Industries): UAE-based generic pharmaceutical manufacturer with strong GCC distribution footprint. Comparable as a regional pharma product supplier operating across the same Gulf institutional channels.
• Jazeera Pharmaceutical Industries (JPI): Saudi-based generic pharmaceutical manufacturer with regional distribution. Comparable as a domestic pharma supplier serving overlapping Saudi and Gulf customers.
• EIPICO (Egyptian International Pharmaceutical Industries Company): One of Egypt's largest generic pharmaceutical manufacturers with MENA distribution. Comparable as a regional pharma supplier targeting overlapping institutional buyers across the Arab world.

Broad incumbents

• Cipla: Global generic pharmaceutical major with significant MENA presence through partners and tenders. Comparable as a broader incumbent supplying the same Saudi institutional channels.
• Hikma Pharmaceuticals: Large MENA-headquartered specialty and generic pharmaceutical company with manufacturing and distribution across the region. Comparable as a broader incumbent competing across overlapping product categories.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights3 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DEEF Pharmaceutical